Drug Discovery & Pharmaceuticals

RSS
Tiny molecule offers hope in reducing opioid side effects

Tiny molecule offers hope in reducing opioid side effects

Harnessing natural biopolymers to develop sustainable antibacterial solutions

Harnessing natural biopolymers to develop sustainable antibacterial solutions

Revolutionizing drug discovery with SmartCADD

Revolutionizing drug discovery with SmartCADD

New deep-learning framework identifies non-addictive pain relief options

New deep-learning framework identifies non-addictive pain relief options

Exploring the venomous potential of marine crustaceans for drug development

Exploring the venomous potential of marine crustaceans for drug development

KiNet web portal enhances study of kinase functions in cellular signaling pathways

KiNet web portal enhances study of kinase functions in cellular signaling pathways

Houston Methodist researchers join national consortium to develop herpesvirus vaccine

Houston Methodist researchers join national consortium to develop herpesvirus vaccine

Quantum discovery shows potential to revolutionize pharmaceutical development

Quantum discovery shows potential to revolutionize pharmaceutical development

Researchers develop technology to change protein identity in vivo

Researchers develop technology to change protein identity in vivo

New AI tool revolutionizes drug discovery for rare diseases

New AI tool revolutionizes drug discovery for rare diseases

CRISPR-Cas13 emerges as a game changer in RNA-targeted therapies

CRISPR-Cas13 emerges as a game changer in RNA-targeted therapies

Urgent call for long-term investment in antibiotic research

Urgent call for long-term investment in antibiotic research

New insights into lasso peptides offer promise for drug development

New insights into lasso peptides offer promise for drug development

Novel drug molecule offers hope for early Parkinson's disease treatment

Novel drug molecule offers hope for early Parkinson's disease treatment

PlaqueTec and RxCelerate collaborate on early phase drug discovery for coronary artery disease

PlaqueTec and RxCelerate collaborate on early phase drug discovery for coronary artery disease

Pushing the limits — Pharma characterization with light scattering

Pushing the limits — Pharma characterization with light scattering

Early specificity testing crucial for antibody drug safety

Early specificity testing crucial for antibody drug safety

New insights into the mechanisms of efavirenz-induced neurotoxicity

New insights into the mechanisms of efavirenz-induced neurotoxicity

SwRI collaborates with UTSA to develop novel chemical process for synthesizing antibiotics

SwRI collaborates with UTSA to develop novel chemical process for synthesizing antibiotics

Evolution of vaccine adjuvants from empirical discovery to rational design

Evolution of vaccine adjuvants from empirical discovery to rational design

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.